Real-World Experience with Non-Metastatic Male Breast Cancer: A 222-Patient Multicenter Study from the Turkish Oncology Group (TOG).

Cancers (Basel) · 2025 · PMC12730629 · PMID 41463146

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Conversely, endocrine therapy showed a trend toward improved DFS but did not reach statistical significance.

also in 53,322 other papers

did not reach statistical significanceno p-value reported

Conversely, endocrine therapy showed a trend toward improved DFS but did not reach statistical significance. HER2-positive patients receiving trastuzumab ( n = 12) had substantially lower recurrence rates (25.0% vs. 52.4%) and markedly improved OS compared with HER2-positive patients who did not receive trastuzumab.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.